Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis

BACKGROUND: Depression is the single largest contributor to non-fatal health loss worldwide. Second-generation antidepressants are the first-line option for pharmacological management of depression. Optimising their use is crucial in reducing the burden of depression; however, debate about their dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Furukawa, Toshi A, Cipriani, Andrea, Cowen, Philip J, Leucht, Stefan, Egger, Matthias, Salanti, Georgia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586944/
https://www.ncbi.nlm.nih.gov/pubmed/31178367
http://dx.doi.org/10.1016/S2215-0366(19)30217-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586944/
https://www.ncbi.nlm.nih.gov/pubmed/31178367
http://dx.doi.org/10.1016/S2215-0366(19)30217-2

Ejemplares similares